Differential Diagnosis and Clinical Treatment Strategies of Thyroid Nodules.
NCT02953288 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000
Last updated 2016-11-02
Summary
To investigate the genetic mutations of patients with thyroid carcinoma and find molecular targets for therapy.
Conditions
Sponsors & Collaborators
-
Shanghai 10th People's Hospital
lead OTHER
Principal Investigators
-
Shen Qu · Sanghai Tenth People's Hospital, Shanghai, China
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-06-30
- Completion
- 2018-12-31
Countries
- China
Study Locations
More Related Trials
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
NCT05395429 ·Status: UNKNOWN
-
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
NCT00316823 ·Status: COMPLETED ·Phase: NA
-
An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules
NCT01307761 ·Status: UNKNOWN
-
Clinical Validation of a Molecular Signature to Detect Cancer in Thyroid Nodules With Indeterminate Cytology
NCT02225509 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
NCT05229341 ·Status: RECRUITING ·Phase: NA
-
Clinical Prediction Thyroid Cancer With Thyroid Ultrasonography
NCT03294005 ·Status: COMPLETED
-
Biomarkers to Distinguish Benign From Malignant Thyroid Neoplasm
NCT01433809 ·Status: COMPLETED
-
Molecular Profile of Thyroid Nodules
NCT05323669 ·Status: UNKNOWN
-
Shared Decision Making in Patients With Thyroid Nodules
NCT02878044 ·Status: COMPLETED ·Phase: NA
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
The Role of Midkine in Diagnosis of Thyroid Cancer
NCT03978351 ·Status: UNKNOWN
-
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
NCT07115810 ·Status: COMPLETED
-
Identification of Molecular Biomarkers for Thyroid Cancer
NCT04133870 ·Status: UNKNOWN
-
Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
NCT06779747 ·Status: RECRUITING
-
Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
NCT00571090 ·Status: COMPLETED
-
Circulating Biomarkers to Identify Thyroid Cancer
NCT04594720 ·Status: COMPLETED
-
Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
NCT03006289 ·Status: UNKNOWN
-
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 ·Status: RECRUITING ·Phase: NA
-
Protein Classifier for Thyroid Indeterminate Nodules
NCT04477798 ·Status: UNKNOWN ·Phase: NA
-
Levothyroxine Treatment in Thyroid Benign Nodular Goiter
NCT00552253 ·Status: COMPLETED ·Phase: NA
-
PACE4 in Thyroid Cancer
NCT03160482 ·Status: COMPLETED
-
Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration
NCT07296575 ·Status: ACTIVE_NOT_RECRUITING
-
Randomized Trial Comparing Performance of Molecular Markers for Indeterminate Thyroid Nodules
NCT02681328 ·Status: ACTIVE_NOT_RECRUITING
-
Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.
NCT05247476 ·Status: UNKNOWN ·Phase: PHASE4